T., B., R., R.K., R., A.C., P., A., S., D. and R., J. 2022. Effect of casirivimab-imdevimab on mild COVID-19 patients with diabetes in reducing oxygen supplementation at 28 days: an observational study. International Journal of Research in Medical Sciences. 10, 9 (Aug. 2022), 1983–1987. DOI:https://doi.org/10.18203/2320-6012.ijrms20222277.